Abstract
Clozapine withdrawal psychosis is a relatively well-recognised phenomenon. However, literature exploring clozapine withdrawal associated catatonia is limited to a few case reports (Bastiampillai et al., 2009). We present a case of clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome (NMS) and discuss its clinical implications.
A better understanding of clozapine withdrawal catatonia and psychosis may also allow us to better analyse the unique properties of clozapine, with possible suggestion that it could be a GABA agent further supporting the importance of the GABA system in schizophrenia (O’Connor and O’Shea, 2015).
A better understanding of clozapine withdrawal catatonia and psychosis may also allow us to better analyse the unique properties of clozapine, with possible suggestion that it could be a GABA agent further supporting the importance of the GABA system in schizophrenia (O’Connor and O’Shea, 2015).
Original language | English |
---|---|
Pages (from-to) | 96-97 |
Number of pages | 2 |
Journal | Asian Journal of Psychiatry |
Volume | 30 |
Early online date | 12 Aug 2017 |
DOIs | |
Publication status | Published - Dec 2017 |
Keywords
- Clozapine
- Withdrawal
- Catatonia
- Psychosis
- Neuroleptic Malignant Syndrome